DALLAS, April 27, 2014 /PRNewswire/ --
ReportsnReports.com offers Next-Generation Sequencing in Latin America market research report by Kalorama Information and Next Generation Sequencing (NGS) Market [Platforms (Illumina HiSeq, MiSeq, Life Technologies Ion Proton/PGM, 454 Roche), Bioinformatics (RNA-Seq, ChIP-Seq), (Pyrosequencing, SBS, SMRT), (Diagnostics, Personalized Medicine)] - Global Forecast to 2017 research report by MarketsandMarkets in its store.
The next generation sequencing market is rapidly evolving with a large number of developments taking place to increase accuracy and speed, and reduce costs of sequencing. It is the fastest-growing and most lucrative segment in the genomics space with an estimated growth of 16.3%. The global NGS market was valued at $1.3 billion in 2012 and is poised to reach $2.7 billion by 2017. By supporting genomics research, various government bodies like NHGRI (National Human Genome Research Institute, U.S.) and Biotechnology and Biological Sciences Research Council (BBSRC, U.K.) are increasing the adoption of high-throughput sequencing platforms. Read more in the report Next Generation Sequencing (NGS) Market [Platforms (Illumina HiSeq, MiSeq, Life Technologies Ion Proton/PGM, 454 Roche), Bioinformatics (RNA-Seq, ChIP-Seq), (Pyrosequencing, SBS, SMRT), (Diagnostics, Personalized Medicine)] - Global Forecast to 2017 available at http://www.reportsnreports.com/reports/257153-next-generation-sequencing-ngs-market-platforms-illumina-hiseq-miseq-life-technologies-ion-proton-pgm-454-roche-bioinformatics-rna-seq-chip-seq-pyrosequencing-sbs-smrt-diagnostics-personalized-medicine-global-forecast-to-2017.html .
Next Generation Sequencing in Latin America market research report by Kalorama Information ( http://www.reportsnreports.com/reports/277071-next-generation-sequencing-in-latin-america.html ) is a look at the use of DNA sequencing systems in the region, based on Survey conducted by VA Consultadoros in Fall 2013. The survey focused on instrumentation, with a goal of providing a complete count of NGS systems sold to customers in key Latin American Countries.
Genomics studies product cycle with Next Generation Sequencing (NGS) technology in Latin America (LatAm) is in its exponential phase and market growth is larger than the regional investment in Science and Technology (S&T) compared against the expenditure in S&T as a percentage of GDP. Because of that is necessary to know more details about the market dynamics, products/applications segmentation and main purchase drivers.
As part of its coverage, this report contains the following data:
Number of Next Generation Sequencing Systems Installed by Country
- • Brazil
- • Mexico
- • Argentina
- • Chile
- • Columbia
- • Others
Brands of Next Generation Sequencing Systems Installed In Latin America, Cross-
Referenced By Country
- • Roche
- • Illumina
- • Life
- • Others
Economic Statistics for Latin American Countries
Scientific and Technical Spending for Latin American Countries
Next Generation Sequencing Systems by Throughput Category
The survey was performed interviewing Distributors with local or regional presence, opinion leaders, manufacturers of systems and reagents for the Life Sciences market segment, research institutes and tender's calls. Twenty two interviews were performed that let gather information about eight countries (Argentina, Brazil, Chile, Colombia, Mexico, Panama, Peru and Uruguay) along the period June/September 2013.
This market survey and analysis shows information about geographical distribution, lab category distribution, manufacturer's analysis, instruments distribution by throughput category and market trends for the coming years. As part of its coverage, applications were not in the scope of this report.
The report is collaboration between Kalorama Information and VA Consultora y Asociados. VA Consultora y Asociados is a consultant company founded and directed by Dr. María Victoria Allais, with more than 20 years in the IVD market and its different segments. Internal knowledge and expertise lead to real time intelligence on the diagnostic market including new technologies and forecasting. In-depth qualitative and quantitative research focused on LATAM region and country specific trends. Order a copy of this report at http://www.reportsnreports.com/Purchase.aspx?name=277071 .
The Next Generation Sequencing (NGS) Market [Platforms (Illumina HiSeq, MiSeq, Life Technologies Ion Proton/PGM, 454 Roche), Bioinformatics (RNA-Seq, ChIP-Seq), (Pyrosequencing, SBS, SMRT), (Diagnostics, Personalized Medicine)] - Global Forecast to 2017 research report says next generation sequencing is set to revolutionize applied markets like diagnostics, drug discovery, biomarker discovery, personalized medicine, and agriculture and animals research. Research institutes and government bodies contribute the highest to the end-user market of NGS; however, the adoption rate in hospitals will increase in the near future due to cost effectiveness, high throughput, and sensitivity. The NGS market will witness a whole new generation of sequencing platforms based on nanapore sequencing technology and fully integrated instruments that could perform all the NGS workflow steps.
Companies profiled in this NGS market report include 454 Life Sciences Corporation (A Roche Company), Agilent Technologies, Inc., BGI (Beijing Genomics Institute), Biomatters, Ltd., CLC Bio, Dnastar, Inc., EMC Corporation, GATC biotech AG, Genomatix Software GMBH, Illumina, Inc., Knome, Inc., Life Technologies Corporation, Macrogen, Inc., Ocimum Biosolutions, Ltd., Oxford Nanorpore Technologies, Ltd., Pacific Biosciences, Partek Incorporated, Perkinelmer, Inc., Qiagen N.V. and Strand Life Sciences Pvt. Ltd. Order a copy of this report at http://www.reportsnreports.com/Purchase.aspx?name=257153 .
Global Next Generation Sequencing Market 2012-2016 report has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market in the Americas, and the EMEA and APAC regions; it also covers the Global Next Generation Sequencing market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market. The key vendors dominating this market space are Illumina Inc., Life Technologies Corp., Roche Holding AG, and Pacific Biosciences of California Inc. The other vendors mentioned in the report are 23andMe Inc., Ambry Genetics Corp., Axeq Technologies Inc., Beijing Genomics Institute, GeneDx, Fluidigm Corp., Foundation Medicine Inc., Good Start Genetics Inc., Helicos BioSciences Corp., Knome Inc., NABsys Inc., Oxford Nanopore Technologies Ltd., Pathogenica Inc., QIAGEN N.V, RainDance Technologies Inc., Sequenom Inc., Takara Bio Inc. Order a copy of this report at http://www.reportsnreports.com/Purchase.aspx?name=268496 .
Explore more reports on the biotechnology market at http://www.reportsnreports.com/market-research/biotechnology/ .
ReportsnReports.com is an online market research reports library of 400,000+ in-depth studies of over 5000 micro markets. Our database includes reports by leading publishers from across the globe. We provide 24/7 online and offline support service to our customers.
TX, Dallas North - Dominion Plaza,
17304, Preston Road,
Suite 800, Dallas 75252
Connect With Us on: